TransMedics Group Inc (TMDX) — Capital Reinvestment Ratio

Latest as of June 2026: 1.05x

TransMedics Group Inc (TMDX) has a Capital Reinvestment Ratio of 1.05x as of June 2026, meaning it reinvests 1% of its operating cash flow ($41.84 Million) in capital expenditures ($43.75 Million). Check TMDX goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

1.05x
Capex / Operating Cash Flow

Operating Cash Flow

$41.84 Million
USD

Capital Expenditures

$43.75 Million
USD

Data as of

Jun 2026
Most recent filing

TransMedics Group Inc Capital Reinvestment Ratio (2024–2025)

This chart tracks TransMedics Group Inc's Capital Reinvestment Ratio across 2 annual periods. For the full cash flow conversion analysis, see TMDX cash generation efficiency.

Annual Capital Reinvestment Ratio for TransMedics Group Inc (2024–2025)

Year-by-year Capital Reinvestment Ratio for TransMedics Group Inc from 2024 to 2025. See cash generation quality of TransMedics Group Inc to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2025 0.31x $192.84 Million $59.25 Million ▼ -88.4%
2024 2.66x $48.80 Million $129.74 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow